1. United States of America Stocks

  2. •

    Healthcare

  3. •

    Medical - Devices
IRadimed Corporation

IRadimed Corporation

IRMD
IRadimed CorporationUS flagNASDAQ Capital Market
91.12
USD
+1.26
- -
1.16BMarket Cap

Total Valuation

IRadimed Corporation carries a market capitalization of 1.16B, placing it among publicly traded companies globally. Its enterprise value stands at 1.17B, reflecting the total theoretical takeover cost after accounting for cash holdings and debt obligations.

Market Cap1.16B
Enterprise Value1.17B

Share Statistics

IRadimed Corporation currently has 12.78M shares outstanding.

Shares Outstanding12.78M
Owned by Insiders (%)N/A
Owned by Institutions (%)N/A

Valuation Ratios

IRadimed Corporation trades at a trailing price-to-earnings ratio of 51.94. The price-to-sales ratio is 14.21, and the price-to-book ratio stands at 18.17.

PE Ratio51.94
PS Ratio14.21
PB Ratio18.17
P/TBV Ratio12.88
P/FCF Ratio37.05
P/OCF Ratio42.37

Enterprise Valuation

On an enterprise value basis, IRadimed Corporation trades at an EV/EBITDA multiple of 39.82 and an EV/FCF ratio of 35.01. The EV/Sales ratio of 13.56 reflects the premium investors are willing to pay for the company's revenue stream, while the EV/EBIT multiple of 41.85 provides insight into valuation relative to core operating earnings.

EV / Sales13.56
EV / EBITDA39.82
EV / EBIT41.85
EV / FCF35.01

Financial Position

IRadimed Corporation maintains a current ratio of 7.13, meaning it holds 7.1x the short-term assets needed to cover near-term liabilities.

Current Ratio7.13
Quick Ratio5.76
Debt / EquityN/A
Debt / EBITDAN/A
Interest CoverageN/A

Financial Efficiency

IRadimed Corporation posts a return on equity of 37.24 and a return on invested capital of 22.62.

Return on Equity (ROE)37.24
Return on Assets (ROA)21.85
Return on Invested Capital (ROIC)22.62
Return on Capital Employed (ROCE)N/A
Revenue Per EmployeeN/A
Employee CountN/A
Inventory Turnover1.78

Taxes

Over the trailing twelve months, IRadimed Corporation has paid 6.57M in income taxes, reflecting an effective tax rate of 21.78.

Income Tax6.57M
Effective Tax Rate21.78

Stock Price Statistics

IRadimed Corporation's stock has gained approximately 49.91774% over the past 52 weeks. The 50-day moving average sits at 91.19, while the 200-day moving average is 88.72.

Beta (5Y)N/A
52-Week Price Change49.91774%
50-Day Moving Average91.19
200-Day Moving Average88.72
Average Volume (20 Days)N/A

Income Statement

Over the trailing twelve months, IRadimed Corporation generated 86.28M in revenue and converted that into 23.61M in net income, yielding earnings per share of 1.84. EBITDA reached 29.38M, while operating income came in at 27.95M.

Revenue86.28M
Gross Profit66.30M
Operating Income27.95M
Pretax Income30.18M
Net Income23.61M
EBITDA29.38M
EBIT27.95M
Earnings Per Share (EPS)1.84

Balance Sheet

Total book value stands at 67.49M, with working capital of 74.30M providing operational flexibility.

Cash & Cash Equivalents56.37M
Total DebtN/A
Net Debt-56.37M
Equity (Book Value)67.49M
Book Value Per Share5.30
Working Capital74.30M

Cash Flow

IRadimed Corporation produced 28.95M in operating cash flow over the past twelve months. After subtracting -4.47M in capital expenditures, free cash flow totaled 24.47M - equivalent to 1.92 per share.

Operating Cash Flow28.95M
Capital Expenditures-4.47M
Free Cash Flow24.47M
FCF Per Share1.92

Margins

IRadimed Corporation operates with a gross margin of 76.84, reflecting its pricing power and cost economics. The operating margin of 32.40 and net profit margin of 27.36 provide insight into operational efficiency.

Gross Margin76.84
Operating Margin32.40
Pretax Margin34.98
Profit Margin27.36
EBITDA Margin34.05

Dividends & Yields

The company's payout ratio of 65.37 indicates the proportion of earnings distributed to shareholders.

Dividend Per Share1.21
Dividend YieldN/A
Payout Ratio65.37
Shareholder Yield1.46
FCF Yield2.70

Scores

IRadimed Corporation posts an Altman Z-Score of 49.61, well above the 3.0 threshold that indicates strong financial health and minimal bankruptcy risk.

Altman Z-Score49.61